trending Market Intelligence /marketintelligence/en/news-insights/trending/ea0bscfh5mgthm10c6q4sq2 content esgSubNav
In This List

OncoCyte names COO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


OncoCyte names COO

Alameda, Calif.-based OncoCyte Corp. appointed Albert Parker as COO.

Previously, Parker served as the managing shareholder of GC Legal Advisors. He has also served as executive vice president, general counsel and corporate secretary at Sunovion Pharmaceuticals Inc.

OncoCyte is a biotechnology company and focuses on developing non-invasive blood and urine diagnostic tests for the early detection of cancer.